FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online January 2, 2003 as doi:10.1096/fj.02-0450fje.
Published as doi: 10.1096/fj.02-0450fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/3/452
02-0450fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DESHPANDE, D. A.
Right arrow Articles by KANNAN, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DESHPANDE, D. A.
Right arrow Articles by KANNAN, M. S.
(The FASEB Journal. 2003;17:452-454.)
© 2003 FASEB

CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness1

DEEPAK A. DESHPANDE, TIMOTHY F. WALSETH*, REYNOLD A. PANETTIERI{dagger} and MATHUR S. KANNAN2

Departments of Veterinary PathoBiology and
* Pharmacology, University of Minnesota, St. Paul, Minnesota, USA; and
{dagger} Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

2Correspondence: Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, USA. E mail: kanna001{at}tc.umn.edu

SPECIFIC AIMS

Airway smooth muscle response to contractile agonists requires elevation of intracellular calcium; in airway inflammatory diseases, smooth muscle produces an exaggerated response to contractile agonists. In the present study, we determined whether inflammatory cytokine-induced human airway smooth muscle cell hyper-responsiveness results from increased CD38 expression and cADPR-induced calcium mobilization.

PRINCIPAL FINDINGS

1. Exposure to the inflammatory cytokines TNF-{alpha}, IL-1ß for IFN-{gamma} increases CD38 expression and ADP-ribosyl cyclase activity
HASM cells arrested at Go of cell cycle were treated with 20 ng/mL of IL-1ß or TNF-{alpha}, 1 IU/mL of IFN-{gamma}, or 0.05% bovine serum albumin for 22 h. CD38 mRNA measured by RT-PCR revealed increased expression in cells exposed to cytokines as compared with controls (Fig. 1 ). Among the cytokines tested, TNF-{alpha} had greater effect on CD38 expression than IL-1ß or IFN-{gamma}. Real-time PCR confirmed quantitative differences in CD38 mRNA expression between control and cytokine-treated cells and between the cytokines. CD38 protein in microsomes obtained from control and cytokine-treated HASM cells was determined by Western blot analysis, using an anti-CD38 antibody. In cytokine-treated cells, there was increased CD38 protein expression vs. controls. TNF-{alpha} treatment of cells resulted in greater CD38 protein expression than the other two cytokines tested in this study. In microsomes prepared from HASM cells treated with inflammatory cytokines, activity of ADP-ribosyl cyclase, which converts ß-NAD to cADPR, was measured by monitoring the conversion of the ß-NAD analog nicotinamide guanine dinucleotide (NGD) to cGDPR using a spectrofluorometer. The specific activities of ADP-ribosyl cyclase were ~3.7-, 1.7-, and 1.9-fold higher in cells treated respectively with TNF-{alpha}, IL-1ß, and IFN-{gamma} than in control.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 1. Inflammatory cytokines increase CD38 mRNA expression in HASM. CD38 mRNA expression in control and cytokine-treated HASM was determined by RT-PCR using human CD38-specific primers and the PCR products were separated on agarose gel. mRNA expression of CD38 was normalized using ß-actin expression, and the relative intensities were determined densitometrically. Upper panel: agarose gel images of representative PCR products obtained from control, IL-1ß (A), TNF-{alpha} (B), and IFN-{gamma} (C). Note increased expression of CD38 mRNA in IL-1ß (A), TNF-{alpha} (B), and IFN-{gamma} (C) -treated HASM cells compared with control. Lower panel: densitometric analysis of CD38 bands in control and cytokine-treated HASM cells normalized with intensities of ß-actin bands in respective treatments. L, 100 bp DNA ladder; T, cytokine-treated HASM cells; C, control HASM cells.

2. The increased CD38 expression in cytokine-treated cells is associated with greater magnitude of [Ca2+]i responses to acetylcholine, bradykinin and thrombin, and greater inhibition of these responses by an antagonist of cyclic ADP-ribose
The [Ca2+]i responses to acetylcholine, bradykinin, and thrombin were measured in Fura-2-loaded HASM cells. In cells exposed to the cytokines, there was a significant augmentation of [Ca2+]i responses to all agonists compared with controls (Fig. 2 ). In control and cytokine-treated cells pretreated with 8-bromo-cADPR, a cell-permeant cADPR antagonist, [Ca2+]i responses to the agonists were attenuated. The magnitude of inhibition of [Ca2+]i responses to the agonists by 8-bromo-cADPR was greater in cytokine-treated cells than in controls. TNF-{alpha} treatment of HASM cells resulted in greater [Ca2+]i responses to the three agonists than the other two cytokines. There was a correlation between level of CD38 expression and magnitude of [Ca2+]i responses to agonists attributable to cADPR.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Treatment of cells with 8Br-cADPR results in attenuated intracellular calcium responses to agonists in control and cytokine-treated HASM cells. Fura-2-loaded control and cytokine-treated HASM cells were incubated with cADPR antagonist and calcium responses to agonists were measured. Net [Ca2+]i in the presence of 8Br-cADPR in control and cytokine-treated cells was compared to corresponding controls (in the absence of 8Br-cADPR). Figure represents the net calcium responses to Ach (left), bradykinin (middle), and thrombin (right) in control and cytokine-treated HASM cells, in the presence or absence of 8Br-cADPR. Note a significant (P<=0.05) attenuation of calcium responses in the presence of 8Br-cADPR in control and cytokine-treated HASM cells. Data are from three different cell preparations.

CONCLUSIONS AND SIGNIFICANCE

The objective of this study was to determine the role of CD38-cADPR signaling in airway hyper-responsiveness. We have demonstrated that inflammatory cytokines up-regulate CD38 expression and ADP-ribosyl cyclase activity, indicating potential for increased cADPR formation in HASM cells. Cytokine treatment resulted in an exaggerated [Ca2+]i response to Ach, BK, and TH; 8Br-cADPR, a cell-permeant cADPR antagonist, attenuated this response, demonstrating a critical role for CD38-cADPR mediated calcium mobilization in airway hyper-responsiveness.

TNF-{alpha} and IL-1ß are known to regulate the expression of many classes of genes, contributing to alteration of airway structure and/or airway responsiveness to agonists. In this study, we have demonstrated up-regulation of CD38 expression by inflammatory cytokines. CD38 is a type II transmembrane glycoprotein that is expressed in a variety of cell types. CD38 expression is highly regulated at multiple levels and is modulated by a variety of physiological and pathological stimuli. CD38 promoter region possesses binding sites for several transcription factors, including interferon-responsive factor 1 (IRF-1) and nuclear factor interleukin 6. Glucocorticoids, estradiol, retinoids, vitamin D3, cyclic-AMP, and cytokines such as IFN-{gamma}, IL-4, and IL-7 have been shown to modulate CD38 expression. Our findings on cytokine effects on CD38 expression suggest possible control at the transcription level.

The hyper-responsiveness observed during airway inflammation is nonspecific in nature. We observed exaggerated [Ca2+]i responses to three different agonists in cytokine-treated ASM cells. The cADPR antagonist attenuated responses to all three agonists in both control and cytokine-treated cells; in cytokine-treated cells, the attenuation was much greater than in controls. These findings indicate that CD38-cADPR signaling is used by multiple agonists for calcium mobilization and that its up-regulation contributes to airway hyper-responsiveness.

Human ASM cells demonstrate hyper-reactivity to agonists that mediate their effects through G-protein-coupled receptors. How stimulation of agonist receptors leads to activation of CD38 and cADPR-mediated calcium mobilization is not clearly understood in smooth muscle cells. In other cell types, it has been demonstrated that activation of ADP-ribosyl cyclase involves G-proteins. In ASM, the effects of Ach are mediated through muscarinic receptors coupled to G{alpha}i- and G{alpha}q-type G-proteins, whereas BK and TH responses are predominantly through G{alpha}q-type G-proteins. The fact that the cADPR antagonist inhibits calcium responses to all three agonists indicates that receptors coupled to both types of G-proteins activate CD38-cADPR signaling in human ASM cells. Furthermore, it has been reported that inflammatory cytokines up-regulate the expression of G-proteins in human ASM cells. This along with the increased CD38 expression may lead to increased cADPR production and airway hyper-responsiveness.

These results provide the first evidence for a role of CD38-cyclic ADP-ribose signaling in airway smooth muscle cell hyper-responsiveness in a model of inflammation (Fig. 3 ).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. A model describing the mechanisms of cytokine-induced ASM hyper-responsiveness. Cytokines up-regulate expression of a multitude of genes including that of CD38 through multiple signal transduction mechanisms (MAPKs, NF-{kappa}B, etc.). The increased second messengers (cADPR, IP3) would result in augmented calcium release through intracellular calcium channels. Dotted arrows represent previously described findings.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.02-0450fje; to cite this article, use FASEB J. (January 2, 2003) 10.1096/fj.02-0450fje




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. Gul, J.-H. Park, S.-Y. Kim, K. Y. Jang, J.-K. Chae, J.-K. Ko, and U.-H. Kim
Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy
Cardiovasc Res, September 11, 2008; (2008) cvn232v2.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Meurs, R. Gosens, and J. Zaagsma
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur. Respir. J., August 1, 2008; 32(2): 487 - 502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. N. Kang, J. A. Jude, R. A. Panettieri Jr., T. F. Walseth, and M. S. Kannan
Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L186 - L193.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
M. Baroffio, E. Crimi, and V. Brusasco
Review: Airway smooth muscle as a model for new investigative drugs in asthma
Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 129 - 139.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
O. Tliba, G. Damera, A. Banerjee, S. Gu, H. Baidouri, S. Keslacy, and Y. Amrani
Cytokines Induce an Early Steroid Resistance in Airway Smooth Muscle Cells: Novel Role of Interferon Regulatory Factor-1
Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
G. E. Hermann and R. C. Rogers
TNF {alpha}: A Trigger of Autonomic Dysfunction
Neuroscientist, February 1, 2008; 14(1): 53 - 67.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
EET Displays Anti-Inflammatory Effects in TNF-{alpha} Stimulated Human Bronchi: Putative Role of CPI-17
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 192 - 201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. G. P. Guedes, J. A. Jude, J. Paulin, H. Kita, F. E. Lund, and M. S. Kannan
Role of CD38 in TNF-{alpha}-induced airway hyperresponsiveness
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L290 - L299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. C. Sieck, T. A. White, M. A. Thompson, C. M. Pabelick, M. E. Wylam, and Y. S. Prakash
Regulation of store-operated Ca2+ entry by CD38 in human airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L378 - L385.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. A. Jude, M. E. Wylam, T. F. Walseth, and M. S. Kannan
Calcium Signaling in Airway Smooth Muscle
Proceedings of the ATS, January 1, 2008; 5(1): 15 - 22.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. J. Sanderson, P. Delmotte, Y. Bai, and J. F. Perez-Zogbhi
Regulation of Airway Smooth Muscle Cell Contractility by Ca2+ Signaling and Sensitivity
Proceedings of the ATS, January 1, 2008; 5(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
O. Tliba and Y. Amrani
Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways
Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H. Matsumoto, L. M Moir, B. G G Oliver, J. K Burgess, M. Roth, J. L Black, and B. E McParland
Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma
Thorax, October 1, 2007; 62(10): 848 - 854.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Hirota, P. Helli, and L. J. Janssen
Ionic mechanisms and Ca2+ handling in airway smooth muscle
Eur. Respir. J., July 1, 2007; 30(1): 114 - 133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. G. Tirumurugaan, J. A. Jude, B. N. Kang, R. A. Panettieri, T. F. Walseth, and M. S. Kannan
TNF-{alpha} induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-{kappa}B and AP-1
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1385 - L1395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Liu, A. M. Freyer, and I. P. Hall
Bradykinin activates calcium-dependent potassium channels in cultured human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L898 - L907.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. C. Rogers, M. J. Van Meter, and G. E. Hermann
Tumor Necrosis Factor Potentiates Central Vagal Afferent Signaling by Modulating Ryanodine Channels
J. Neurosci., December 6, 2006; 26(49): 12642 - 12646.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. G. P. Guedes, J. Paulin, L. Rivero-Nava, H. Kita, F. E. Lund, and M. S. Kannan
CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1286 - L1293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. F. Ethier and J. M. Madison
Adenosine A1 Receptors Mediate Mobilization of Calcium in Human Bronchial Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. A. White, A. Xue, E. N. Chini, M. Thompson, G. C. Sieck, and M. E. Wylam
Role of Transient Receptor Potential C3 in TNF-{alpha}-Enhanced Calcium Influx in Human Airway Myocytes
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Fayon, M. Rebola, P. Berger, S. Daburon, O. Ousova, F. Lavrand, B. Moukaila, W. Pujol, J. L. Taupin, A. Labbe, et al.
Increased secretion of leukemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signaling and airway contractility
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L244 - L251.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B.-N. Kang, K. G. Tirumurugaan, D. A. Deshpande, Y. Amrani, R. A. Panettieri, T. F. Walseth, and M. S. Kannan
Transcriptional regulation of CD38 expression by tumor necrosis factor-{alpha} in human airway smooth muscle cells: role of NF-{kappa}B and sensitivity to glucocorticoids
FASEB J, May 1, 2006; 20(7): 1000 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Zhang, E. G. Teggatz, A. Y. Zhang, M. J. Koeberl, F. Yi, L. Chen, and P.-L. Li
Cyclic ADP ribose-mediated Ca2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1172 - H1181.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Tliba, J. A. Cidlowski, and Y. Amrani
CD38 Expression Is Insensitive to Steroid Action in Cells Treated with Tumor Necrosis Factor-{alpha} and Interferon-{gamma} by a Mechanism Involving the Up-Regulation of the Glucocorticoid Receptor beta Isoform
Mol. Pharmacol., February 1, 2006; 69(2): 588 - 596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. H. Kim, D. Jain, O. Tliba, B. Yang, W. F. Jester Jr., R. A. Panettieri Jr., Y. Amrani, and E. Pure
TGF-{beta} potentiates airway smooth muscle responsiveness to bradykinin
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L511 - L520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Du, J. A. Stiber, P. B. Rosenberg, G. Meissner, and J. P. Eu
Ryanodine Receptors in Muscarinic Receptor-mediated Bronchoconstriction
J. Biol. Chem., July 15, 2005; 280(28): 26287 - 26294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. A. Deshpande, T. A. White, S. Dogan, T. F. Walseth, R. A. Panettieri, and M. S. Kannan
CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L773 - L788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Naik, C. K. Billington, R. M. Pascual, D. A. Deshpande, F. P. Stefano, T. A. Kohout, D. M. Eckman, J. L. Benovic, and R. B. Penn
Regulation of Cysteinyl Leukotriene Type 1 Receptor Internalization and Signaling
J. Biol. Chem., March 11, 2005; 280(10): 8722 - 8732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Deshpande, T. A. White, A. G. P. Guedes, C. Milla, T. F. Walseth, F. E. Lund, and M. S. Kannan
Altered Airway Responsiveness in CD38-Deficient Mice
Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Carbajal, M. H. Vargas, E. Flores-Soto, E. Martinez-Cordero, B. Bazan-Perkins, and L. M. Montano
LTD4 induces hyperresponsiveness to histamine in bovine airway smooth muscle: role of SR-ATPase Ca2+ pump and tyrosine kinase
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L84 - L92.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Sakai, S. Otogoto, Y. Chiba, K. Abe, and M. Misawa
Involvement of p42/44 MAPK and RhoA protein in augmentation of ACh-induced bronchial smooth muscle contraction by TNF-{alpha} in rats
J Appl Physiol, December 1, 2004; 97(6): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Thompson, H. Barata da Silva, W. Zielinska, T. A. White, J. P. Bailey, F. E. Lund, G. C. Sieck, and E. N. Chini
Role of CD38 in myometrial Ca2+ transients: modulation by progesterone
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1142 - E1148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Tliba, R. A. Panettieri Jr., S. Tliba, T. F. Walseth, and Y. Amrani
Tumor Necrosis Factor-{alpha} Differentially Regulates the Expression of Proinflammatory Genes in Human Airway Smooth Muscle Cells by Activation of Interferon-{beta}-Dependent CD38 Pathway
Mol. Pharmacol., August 1, 2004; 66(2): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Deshpande, S. Dogan, T. F. Walseth, S. M. Miller, Y. Amrani, R. A. Panettieri, and M. S. Kannan
Modulation of Calcium Signaling by Interleukin-13 in Human Airway Smooth Muscle: Role of CD38/Cyclic Adenosine Diphosphate Ribose Pathway
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Dogan, D. A. Deshpande, M. S. Kannan, and T. F. Walseth
Changes in CD38 Expression and ADP-Ribosyl Cyclase Activity in Rat Myometrium During Pregnancy: Influence of Sex Steroid Hormones
Biol Reprod, July 1, 2004; 71(1): 97 - 103.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Barata, M. Thompson, W. Zielinska, Y. S. Han, C. B. Mantilla, Y. S. Prakash, S. Feitoza, G. Sieck, and E. N. Chini
The Role of Cyclic-ADP-Ribose-Signaling Pathway in Oxytocin-Induced Ca2+ Transients in Human Myometrium Cells
Endocrinology, February 1, 2004; 145(2): 881 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Partida-Sanchez, P. Iribarren, M. E. Moreno-Garcia, J.-L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, and F. E. Lund
Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose
J. Immunol., February 1, 2004; 172(3): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Chen, O. Tliba, C. R. Van Besien, R. A. Panettieri Jr., and Y. Amrani
Selected Contribution: TNF-{alpha} modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl
J Appl Physiol, August 1, 2003; 95(2): 864 - 872.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/3/452
02-0450fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DESHPANDE, D. A.
Right arrow Articles by KANNAN, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DESHPANDE, D. A.
Right arrow Articles by KANNAN, M. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS